Case reports on mistletoe therapy for ovarian cancer
Last update: June 15th, 2023/AT1
Case 1
Long-term tumour-free survival in a patient with stage IV epithelial ovarian cancer undergoing high-dose chemotherapy and Viscum album extract treatment: a case report
Werthmann PG et al. 2019 [263]
A 50-year-old female patient with metastatic epithelial ovarian cancer received post-surgical subcutaneous mistletoe therapy in addition to high-dose chemotherapy and subsequent autologous stem cell transplantation. After termination of chemotherapy, mistletoe treatment was continued. After 20 years, the patient still has a good quality of life with no tumours.
Last update: June 15th, 2023/AT1
Case 2
Prolonged stabilization of platinum-refractory ovarian cancer in a single patient undergoing long-term mistletoe extract treatment: a case report
Hwang WY et al. 2019 [262]
A 47-year-old female patient with stage IVb platinum-refractory ovarian cancer has been progression-free after adjuvant mistletoe therapy for 42 months since initial diagnosis and 24 months since the last relapse.
Last update: June 15th, 2023/AT1
